Cellectar Biosciences, Inc. Quarterly Return On Equity in % from Q1 2012 to Q1 2024

Taxonomy & unit: ratio: %
Description: Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary: Cellectar Biosciences, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q1 2024.
Cellectar Biosciences, Inc. Return On Equity for the quarter ending March 31, 2024 was -1.86K %, a 734% decline year-over-year.
Cellectar Biosciences, Inc. annual Return On Equity for 2023 was 1.94K %.
Cellectar Biosciences, Inc. annual Return On Equity for 2022 was -151 %, a 159% decline from 2021.
Cellectar Biosciences, Inc. annual Return On Equity for 2021 was -58.3 %, a 7% increase from 2020.

Return On Equity, Quarterly (%)

Return On Equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date
Q1 2024	-1.86K	-1.63K	-734%	Jan 1, 2024	Mar 31, 2024
Q4 2023	1.94K	+2.09K		Oct 1, 2023	Dec 31, 2023
Q3 2023	-1.67K	-1.56K	-1328%	Jul 1, 2023	Sep 30, 2023
Q2 2023	-362	-277	-326%	Apr 1, 2023	Jun 30, 2023
Q1 2023	-223	-156	-232%	Jan 1, 2023	Mar 31, 2023
Q4 2022	-151	-92.9	-159%	Oct 1, 2022	Dec 31, 2022
Q3 2022	-117	-70.6	-151%	Jul 1, 2022	Sep 30, 2022
Q2 2022	-85.1	-36.7	-76%	Apr 1, 2022	Jun 30, 2022
Q1 2022	-67	-17.2	-34.7%	Jan 1, 2022	Mar 31, 2022
Q4 2021	-58.3	+4.39	+7%	Oct 1, 2021	Dec 31, 2021
Q3 2021	-46.6	+71	+60.4%	Jul 1, 2021	Sep 30, 2021
Q2 2021	-48.3	+79.4	+62.2%	Apr 1, 2021	Jun 30, 2021
Q1 2021	-49.7	+86	+63.4%	Jan 1, 2021	Mar 31, 2021
Q4 2020	-62.7	+56.9	+47.6%	Oct 1, 2020	Dec 31, 2020
Q3 2020	-118	-4.34	-3.83%	Jul 1, 2020	Sep 30, 2020
Q2 2020	-128	-30.2	-30.9%	Apr 1, 2020	Jun 30, 2020
Q1 2020	-136	-15.9	-13.3%	Jan 1, 2020	Mar 31, 2020
Q4 2019	-120	+5.57	+4.45%	Oct 1, 2019	Dec 31, 2019
Q3 2019	-113	+22.3	+16.4%	Jul 1, 2019	Sep 30, 2019
Q2 2019	-97.6	+85.3	+46.6%	Apr 1, 2019	Jun 30, 2019
Q1 2019	-120	+34.6	+22.4%	Jan 1, 2019	Mar 31, 2019
Q4 2018	-125	+1.09	+0.86%	Oct 1, 2018	Dec 31, 2018
Q3 2018	-136	-30.1	-28.5%	Jul 1, 2018	Sep 30, 2018
Q2 2018	-183	-87.9	-92.6%	Apr 1, 2018	Jun 30, 2018
Q1 2018	-154	-66.1	-74.8%	Jan 1, 2018	Mar 31, 2018
Q4 2017	-126	-52.8	-72%	Oct 1, 2017	Dec 31, 2017
Q3 2017	-106	-57	-117%	Jul 1, 2017	Sep 30, 2017
Q2 2017	-94.9	-34.8	-57.8%	Apr 1, 2017	Jun 30, 2017
Q1 2017	-88.3	+41.9	+32.2%	Jan 1, 2017	Mar 31, 2017
Q4 2016	-73.4	+163	+69%	Oct 1, 2016	Dec 31, 2016
Q3 2016	-48.6	+225	+82.2%	Jul 1, 2016	Sep 30, 2016
Q2 2016	-60.1	+69.2	+53.5%	Apr 1, 2016	Jun 30, 2016
Q1 2016	-130	+29	+18.2%	Jan 1, 2016	Mar 31, 2016
Q4 2015	-237	+5.49	+2.27%	Oct 1, 2015	Dec 31, 2015
Q3 2015	-273	+143	+34.4%	Jul 1, 2015	Sep 30, 2015
Q2 2015	-129	+1.31K	+91%	Apr 1, 2015	Jun 30, 2015
Q1 2015	-159	+220	+58%	Jan 1, 2015	Mar 31, 2015
Q4 2014	-242	-11.4	-4.95%	Oct 1, 2014	Dec 31, 2014
Q3 2014	-417	-284	-215%	Jul 1, 2014	Sep 30, 2014
Q2 2014	-1.44K	-1.32K	-1077%	Apr 1, 2014	Jun 30, 2014
Q1 2014	-379	-272	-254%	Jan 1, 2014	Mar 31, 2014
Q4 2013	-231	-137	-145%	Oct 1, 2013	Dec 31, 2013
Q3 2013	-132	-38.7	-41.3%	Jul 1, 2013	Sep 30, 2013
Q2 2013	-122	-21.5	-21.4%	Apr 1, 2013	Jun 30, 2013
Q1 2013	-107	+9.35	+8.04%	Jan 1, 2013	Mar 31, 2013
Q4 2012	-94			Oct 1, 2012	Dec 31, 2012
Q3 2012	-93.7			Jul 1, 2012	Sep 30, 2012
Q2 2012	-101			Apr 1, 2012	Jun 30, 2012
Q1 2012	-116			Jan 1, 2012	Mar 31, 2012

* An asterisk sign (*) next to the value indicates that the value is likely invalid.